Fredrik Kahn
11 – 20 of 54
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population–first results from a cohort study in Southern Sweden
(
- Contribution to journal › Article
-
Mark
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
(
- Contribution to journal › Article
-
Mark
The Dynamics of Circulating Heparin-Binding Protein : Implications for Its Use as a Biomarker
(
- Contribution to journal › Article
-
Mark
COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022
2022) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(18).(
- Contribution to journal › Article
-
Mark
COVID-19 vaccine effectiveness against severe disease from the Omicron BA.1 and BA.2 subvariants: surveillance results from southern Sweden, December 2021 to March 2022
2022)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Surveillance of COVID-19 vaccine effectiveness : A real-time case-control study in southern Sweden
(
- Contribution to journal › Article
-
Mark
Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022
2022) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(9).(
- Contribution to journal › Article
-
Mark
The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis - results from the south-Swedish juvenile idiopathic arthritis cohort
(
- Contribution to journal › Article
-
Mark
One Scoring System Does Not Fit All Healthcare Settings
2022) In Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74(1). p.166-167(
- Contribution to journal › Letter
-
Mark
Treatment outcome with pencillin G or cloxacillin in penicillin susceptible Staphylococcus aureus bactearemi
(
- Contribution to journal › Article